We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

601216:SSEInner Mongolia Junzheng Energy & Chemical Group Co., Ltd. Class A Analysis

Data as of 2026-03-12 - not real-time

CN¥6.68

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The stock is trading at 6.68 CNY, comfortably above its 20‑day (6.01), 50‑day (5.65) and 200‑day (5.38) moving averages, signalling a strong bullish bias. Technical momentum is reinforced by a bullish MACD crossover (line 0.22 above signal 0.18) and an RSI of 68, indicating continued buying pressure without yet being overbought. Volume is on an upward trend, supporting the price advance, while the 30‑day volatility of roughly 41% suggests sizable price swings. Despite the momentum, the computed beta of 0.08 points to very low market‑wide sensitivity, which can cushion broader market moves.
Fundamentally, the company faces a 10% revenue contraction and a forward PE of 33.4, implying earnings are expected to fall sharply, and a discounted cash‑flow fair value of just 4.07 CNY marks the current price as materially overvalued. Nevertheless, profitability remains solid with a 13% net margin, 12% ROE, and a dividend yield of 2.33% supported by a payout ratio under 40%, suggesting dividend sustainability. The balance sheet shows moderate leverage (debt‑to‑equity ~20%) and ample operating cash flow, but the net‑debt position tempers optimism. Overall, the stock blends bullish technicals with value‑oriented fundamentals, making a nuanced outlook appropriate.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price above all major moving averages
  • Bullish MACD and rising volume
  • High short‑term volatility

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • Revenue decline of 10% YoY
  • Forward PE of 33.4 indicating earnings pressure
  • Current price exceeds DCF fair value

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Sustainable dividend yield of 2.33% with low payout ratio
  • Stable ROE around 12% and solid cash flow generation
  • Very low beta reducing market‑wide risk

Key Metrics & Analysis

Financial Health

Revenue Growth-10.40%
Profit Margin13.18%
P/E Ratio16.7
ROE12.02%
ROA5.04%
Debt/Equity20.55
P/B Ratio2.0
Op. Cash FlowCN¥5.1B
Free Cash FlowCN¥2.5B

Technical Analysis

TrendBullish
RSI68.4
SupportCN¥5.45
ResistanceCN¥6.75
MA 20CN¥6.01
MA 50CN¥5.65
MA 200CN¥5.38
MACDBullish
VolumeIncreasing
Fear & Greed Index75.02

Valuation

Fair ValueCN¥4.07
GradeOvervalued
TypeValue
Dividend Yield2.33%

Risk Assessment

Beta0.08
Volatility40.83%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.